137 related articles for article (PubMed ID: 35202759)
1. Does Postoperative Intravenous Ferric Carboxymaltose Hasten the Recovery of Hemoglobin in Patients Post Total Knee Arthroplasty?
Maniar AR; Mishra A; Sanghavi N; Maniar RN
J Arthroplasty; 2022 Jun; 37(6S):S155-S158. PubMed ID: 35202759
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
Bisbe E; Moltó L; Arroyo R; Muniesa JM; Tejero M
Br J Anaesth; 2014 Sep; 113(3):402-9. PubMed ID: 24780615
[TBL] [Abstract][Full Text] [Related]
3. Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.
Lichtenstein GR; Onken JE
Dig Dis Sci; 2018 Nov; 63(11):3009-3019. PubMed ID: 30056562
[TBL] [Abstract][Full Text] [Related]
4. Immediate intravenous iron administration improves anaemia recovery following total knee arthroplasty: A propensity-matched analysis.
Park HS; Bin SI; Kim HJ; Kim J; Kim H; Ro Y; Koh WU
Vox Sang; 2022 Feb; 117(2):243-250. PubMed ID: 34270101
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
Bailie GR
Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study.
Lee S; Ryu KJ; Lee ES; Lee KH; Lee JJ; Kim T
J Obstet Gynaecol Res; 2019 Apr; 45(4):858-864. PubMed ID: 30932300
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Ferric Carboxymaltose Improves Response to Postoperative Anemia Following Total Knee Arthroplasty: A Prospective Randomized Controlled Trial in Asian Cohort.
Choi KY; Koh IJ; Kim MS; Kim C; In Y
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566482
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
Geisser P; Rumyantsev V
Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
Naqash A; Ara R; Bader GN
BMC Womens Health; 2018 Jan; 18(1):6. PubMed ID: 29304848
[TBL] [Abstract][Full Text] [Related]
11. Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals.
Lucas J; Costa E; Subtil A; Sequeira R; Campos Fernandes A; Robalo Nunes A; Sousa P
Sci Rep; 2022 Nov; 12(1):19335. PubMed ID: 36369296
[TBL] [Abstract][Full Text] [Related]
12. Short-term high-dose intravenous iron reduced peri-operative transfusion after staggered bilateral total knee arthroplasty: A retrospective cohort study.
Park HS; Bin SI; Kim HJ; Kim TY; Kim J; Kim H; Ro Y; Koh WU
Vox Sang; 2022 Apr; 117(4):562-569. PubMed ID: 34897718
[TBL] [Abstract][Full Text] [Related]
13. Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.
Calleja JL; Delgado S; del Val A; Hervás A; Larraona JL; Terán Á; Cucala M; Mearin F;
Int J Colorectal Dis; 2016 Mar; 31(3):543-51. PubMed ID: 26694926
[TBL] [Abstract][Full Text] [Related]
14. Impact of ferric carboxymaltose on the evolution of hemoglobin and ECOG performance status in iron-deficient patients with solid tumors: a 3-month follow-up retrospective study.
Coussirou J; Debourdeau A; Stancu A; Jean C; Azouza W; Chanet B; De Crozals F; Boustany R; Debourdeau P
Support Care Cancer; 2018 Nov; 26(11):3827-3834. PubMed ID: 29797080
[TBL] [Abstract][Full Text] [Related]
15. Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department.
Motta I; Mantovan G; Consonni D; Brambilla AM; Materia M; Porzio M; Migone De Amicis M; Montano N; Cappellini MD
Intern Emerg Med; 2020 Jun; 15(4):629-634. PubMed ID: 31707563
[TBL] [Abstract][Full Text] [Related]
16. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery.
Nugara C; Vitale G; Caccamo G; Sarullo S; Giallauria F; Di Franco A; Vitale S; Sarullo FM
Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32124586
[TBL] [Abstract][Full Text] [Related]
19. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
Evstatiev R; Marteau P; Iqbal T; Khalif IL; Stein J; Bokemeyer B; Chopey IV; Gutzwiller FS; Riopel L; Gasche C;
Gastroenterology; 2011 Sep; 141(3):846-853.e1-2. PubMed ID: 21699794
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.
Covic A; Mircescu G
Nephrol Dial Transplant; 2010 Aug; 25(8):2722-30. PubMed ID: 20190247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
